Show simple item record

dc.contributor.authorDeciphering Developmental Disorders Study
dc.date.accessioned2018-04-16T13:21:00Z
dc.date.issued2017-01-25
dc.description.abstractThe genomes of individuals with severe, undiagnosed developmental disorders are enriched in damaging de novo mutations (DNMs) in developmentally important genes. Here we have sequenced the exomes of 4,293 families containing individuals with developmental disorders, and meta-analysed these data with data from another 3,287 individuals with similar disorders. We show that the most important factors influencing the diagnostic yield of DNMs are the sex of the affected individual, the relatedness of their parents, whether close relatives are affected and the parental ages. We identified 94 genes enriched in damaging DNMs, including 14 that previously lacked compelling evidence of involvement in developmental disorders. We have also characterized the phenotypic diversity among these disorders. We estimate that 42% of our cohort carry pathogenic DNMs in coding sequences; approximately half of these DNMs disrupt gene function and the remainder result in altered protein function. We estimate that developmental disorders caused by DNMs have an average prevalence of 1 in 213 to 1 in 448 births, depending on parental age. Given current global demographics, this equates to almost 400,000 children born per year.en_GB
dc.description.sponsorshipThe DDD study presents independent research commissioned by the Health Innovation Challenge Fund (grant HICF-1009-003), a parallel funding partnership between the Wellcome Trust and the UK Department of Health, and the Wellcome Trust Sanger Institute (grant WT098051). The views expressed in this publication are those of the author(s) and not necessarily those of the Wellcome Trust or the UK Department of Health. The research team acknowledges the support of the National Institutes for Health Research, through the Comprehensive Clinical Research Network. D.R.F. is funded through an MRC Human Genetics Unit program grant to the University of Edinburgh.en_GB
dc.identifier.citationVol. 542, pp. 433 - 438en_GB
dc.identifier.doi10.1038/nature21062
dc.identifier.urihttp://hdl.handle.net/10871/32468
dc.language.isoenen_GB
dc.publisherSpringer Natureen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/28135719en_GB
dc.rights© 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.en_GB
dc.subjectAdolescenten_GB
dc.subjectAdulten_GB
dc.subjectAutoantigensen_GB
dc.subjectCDC2 Protein Kinaseen_GB
dc.subjectCasein Kinase IIen_GB
dc.subjectChilden_GB
dc.subjectCohort Studiesen_GB
dc.subjectDEAD-box RNA Helicasesen_GB
dc.subjectDNA-Binding Proteinsen_GB
dc.subjectDevelopmental Disabilitiesen_GB
dc.subjectExomeen_GB
dc.subjectFemaleen_GB
dc.subjectHeredityen_GB
dc.subjectHistone-Lysine N-Methyltransferaseen_GB
dc.subjectHomeodomain Proteinsen_GB
dc.subjectHumansen_GB
dc.subjectMaleen_GB
dc.subjectMi-2 Nucleosome Remodeling and Deacetylase Complexen_GB
dc.subjectMiddle Ageden_GB
dc.subjectMutationen_GB
dc.subjectMyeloid-Lymphoid Leukemia Proteinen_GB
dc.subjectNerve Tissue Proteinsen_GB
dc.subjectParentsen_GB
dc.subjectPhenotypeen_GB
dc.subjectPrevalenceen_GB
dc.subjectProtein Phosphatase 2Cen_GB
dc.subjectRepressor Proteinsen_GB
dc.subjectSequence Analysis, DNAen_GB
dc.subjectSex Characteristicsen_GB
dc.subjectTranscription Factorsen_GB
dc.subjectYoung Adulten_GB
dc.subjectras GTPase-Activating Proteinsen_GB
dc.titlePrevalence and architecture of de novo mutations in developmental disordersen_GB
dc.typeArticleen_GB
dc.date.available2018-04-16T13:21:00Z
dc.identifier.issn0028-0836
exeter.place-of-publicationEnglanden_GB
dc.descriptionThis is the author accepted manuscript. The final version is available from Nature via the DOI in this record.en_GB
dc.identifier.journalNatureen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record